Global Minimal Residual Disease Market Share

Statistics for the 2023 & 2024 Global Minimal Residual Disease market share, created by Mordor Intelligence™ Industry Reports. Global Minimal Residual Disease share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Global Minimal Residual Disease Market Market Share

Market Share of Global Minimal Residual Disease Industry

The minimal residual disease market is highly competitive and consists of several major players. The companies are investing in research and development activities to provide patients with better treatment and detection methods and adopt various business strategies such as collaboration and acquisitions to withhold their positions in the market. Some key players are Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, and Amgen Inc.

Minimal Residual Disease Market Leaders

  1. Adaptive Biotechnologies

  2. Bristol-Myers Squibb Company

  3. Kite Pharma

  4. Natera

  5. Amgen Inc.

*Disclaimer: Major Players sorted in no particular order

Adaptive Biotechnologies, Bristol-Myers Squibb Company, Kite Pharma, Natera, Amgen Inc.

Global Minimal Residual Disease Report Snapshots

Minimal Residual Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)